Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.

Advanced drug delivery reviews - 20 May 2009

Sakaeda Toshiyuki, Yamamori Motohiro, Kuwahara Akiko, Nishiguchi Kohshi

Abstract excerpt

Esophageal cancer is one of the most lethal malignancies. Surgical resection of the tumor from the primary site has been the standard treatment, especially for localized squamous cell carcinoma, but considerable clinical efforts during the last decade have resulted in novel courses of treatment. These options include chemoradiotherapy, consisting of a continuous infusion of 5-fluorouracil (5-FU), cisplatin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers
Share to Esophageal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pharmacogenetics

Source

Identifiers

PMID: 19135108
DOI: 10.1016/j.addr.2008.10.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.PMID 19135108Read ↗

Esophageal cancer: Risk factors, genetic association, and treatment.Semantic proximity Read ↗

Molecular mechanisms associated with chemoresistance in esophageal cancer.Semantic proximity Read ↗

Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.Semantic proximity Read ↗

Personalized targeted therapy for esophageal squamous cell carcinoma.Semantic proximity Read ↗

MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction ChemoradiotherapySemantic proximity Read ↗

Genomics of Esophageal Cancer and Biomarkers for Early Detection.Semantic proximity Read ↗

Targeted Therapies in Neoadjuvant Treatment for Gastroesophageal CancerSemantic proximity Read ↗

Radiomics in esophageal and gastric cancer.Semantic proximity Read ↗

Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.Semantic proximity Read ↗

GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.Semantic proximity Read ↗

Epidemiological studies of esophageal cancer in the era of genome-wide association studiesSemantic proximity Read ↗

A review of the current understanding and clinical utility of miRNAs in esophageal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.